Health
ERS Genomics Appoints Michael Arciero As Vice-President of Intellectual Property & Commercial Development – Technology Networks
Michael previously led the technology transfer team at USC Stevens Center for Innovation in his capacity as Director of Technology Commercialisation.
ERS Genomics Limited (ERS), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Michael Arciero as Vice-President of Intellectual Property and Commercial Development. In the new role, Michael will oversee the intellectual property portfolio of the company and will become a core member of the Company’s global business development team.Michael has over 15 years of experience i…
-
Noosa News17 hours agoProtest calls for shark net removal
-
General16 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News19 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
Noosa News10 hours agoPrime Minister Anthony Albanese calls for political temperature to be ‘turned down’ after alleged death threat